Streszczenie

1. American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders, 4 th edition, Text Revised (DSM-IV-TR). Washington, DC, American Psychiatric Association, 2000. 2. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania w ICD – 10: badawcze kryteria diagnostyczne. (1998). Tłum. Wciórka, J. Uniwersyteckie Wydawnictwo Medyczne ”Vesalius”. Instytut Psychiatrii i Neurologii: Kraków-Warszawa. Wg: The ICD – 10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostic Guidelines. World Health Organization. Geneva. 1992, 262-266. 3. Taylor, E., Sandberg, S. T., Thorley, G., Giles, S. (1991). The Epidemiology of Childhood Hyperactivity. Maudsley Monographs 33. Oxford. Oxford University Press. 4. Buitelaar, J. K. (2002). Epidemiology of Attention Deficyt/Hyperactivity Disorder: What have we learned over the last decade? W: Sandberg, S. T. (red.): Hyperactivity Disorders. Cambridge. Cambridge University Press.  5. Kent, L. (2004). Recent advances in the genetics of attention -deficit/hyperactivity disorder. Curr. Psychiatry Rep. 6, 143-148.  6. Thapar, A., Holmes, J., Poulton, K., Harrington, R. (1999). Genetic basis of attention deficit and hyperactivity. Br J Psychiatry. 174, 105-111.  7. Maher, B. S., Marazita, M. L., Ferell, R. E., Vanyukov, M. M. (2002). Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Gen. 12, 207-215. 8. Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., Steinhausen, H-C., Zuddas, A. (2004). European clinical guidelines for hyperkinetic disorder – first upgrade. Eur. Child Adolesc. Psychiatry (Suppl 1). 13, 1, 1/7 -1/30. 9. Berger, A., Posner, M. I. (2000). Pathologies of brain attentional networks. Neurosci Biobehav. Rev. 24, 3-5. 10. Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., Steinhausen, H-C., Zuddas, A. (2004). op. cit. 11. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C. R., Simmons, A., Bullmore, E. T. (1999). Hypofrontality in Attention Deficit Hyperactivity Disorder During Higher-Order Motor Control: A Study with Functional MRI. Am. J Psychiatry. 156, 6, June, 891-896. 12. Kutcher, S., Aman, M., Brookes, S. j., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R. L., Fisman, S., Greenhill, L. L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., Tyano, S. (2004). International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs): Clinical imlications and treatment practice suggestions. Europ. Neuropsychopharmacol. 14, 11-28.  13. Sowell, E. R., Thompson, P. M., Welcome, S. E., Henkenius, A. L., Toga, A. W., Peterson, B. S. (2003). Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet. 362 (9397), 1699-1707. 14. Giedd, J. N., Blumenthal, J., Molloy, E., Castellanos, F. X. (2001). Brain Imaging of Attention Deficit/Hyperactivity Disorder. Ann. NY Acad. Sci. 931, 33-49. 15. Rappley, M. D. (2005). Attention deficit-hiperactivity disorder. New Engl. J Med. 352, 165-173.  16. Biederman, J., Milberger, S., Faraone, S. V., Kiely, K., Guite, J., Mick, E., Ablon, S., Warburton, R., Reed,  E. (1995). Family – environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch. Gen. Psychiatry. 52, 464-470. 17. Rutter, M., Roy, P., Kreppner, J. (2002). Institutional care as a risk factor for inattention/overactivity. W: Sandberg, S.(red): Hyperactivity and Attention Disorders of Childhood. 2-gie wyd. Cambridge. Cambridge University Press 18. Diagnostic and Statistical Manual of Mental Disorders. (2000). op. cit.  19. Faraone, S. V., Biederman, J., Monuteaux, M. C. (2001). A psychometric measure of learning disability predicts educational failure four years later in boys with ADHD. J Atten Disord. 4, 220-230. 20. Dąbkowska, M. (2008). Styl atrybucji oraz funkcjonowanie społeczne adolescentów z zespołem nadpobudliwości z zaburzeniami koncentracji uwagi. Toruń. Wydawnictwo Naukowe UMK. 21. American Academy of Pediatrics. (2001). Clinical practice guideline: treatment of the school-aged child with Attention-Deficit/Hyperactivity Disorder. Pediatrics. 108, 4, s. 1033-1044. 22. Barkley, R. A. (2004). Adolescents with attention-deficit/hyperactivity disorder: An overview of empirically based treatments. J. Psychiatr. Pract. 10, 39-56. 23. Anostopoulos, A., D., Farley, S., E. (2006). Program treningu poznawczo-behewioralnego dla rodziców dzieci z zespołem nadpobudliwości ruchowej z zaburzeniami koncentracji uwagi. W: Kazdin, A., E., Weisz, J., R. Psychoterapia dzieci i młodzieży. Wydawnictwo Uniwersytetu Jagiellońskiego: Kraków. 24.  Anostopoulos, A., D., Farley, S., E. (2006). Program treningu poznawczo-behewioralnego dla rodziców dzieci z zespołem nadpobudliwości ruchowej z zaburzeniami koncentracji uwagi. W: Kazdin, A., E., Weisz, J., R. Psychoterapia dzieci i młodzieży. Wydawnictwo Uniwersytetu Jagiellońskiego: Kraków. 25.  Antshel, K. M., Barkley, R. (2008). Psychosocial intervention in attention deficit hyperactivity disorder. Child Adolesc Psychiatry Clin N Am. 17, 421-437.  Dąbkowski, M. (2007). Zespół nadpobudliwości psychoruchowej z deficytem uwagi. Przewodnik Lekarza. 2, 94, 232-239. 26. Kazdin, A. E., Weisz, J. R. (2006). Psychoterapia dzieci i młodzieży. Metody oparte na dowodach. Wydawnictwo Uniwersytetu Jagiellońskiego: Kraków.  27. MTA Cooperative Group. (1999). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 56, s. 1088-1096. 28.  Dziennik Ustaw z 2004. Nr 199. Pozycja 2046, z późniejszymi zmianami. 29. Wehmeier, P., Schacht, A., Barkley, R. A. (2010). Social and Emotional impairment in Children and Adolescents with ADHD and the impact on Quality of Life. J Adolesc Health. 46, 3, 209-217.  30. Froehlich, T. E., Lanphear, B. P., Epstein, J. N., Barbaresi, W. J., Katusic, S. K., Kahn, R. S. (2007). Prevalence, recognition, and treatment of Attention-Deficit/Hyperactivity Disorder in a national sample of US children. Arch of Pediatrics and Adolesc Med. 1, 161 (9), 857-864. 31.  Borden, K. A., Brown, R. T. (1989). Attributional outcomes: the subtle message of treatments for attention deficit disorder. Cognitive Ther Res. 13, 147-160. 32.  Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donell, D., Griffin, S. (1996). Pharmacotherapy of attention deficit/-hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 35, 409-432. 33. Kutcher, S., Aman, M., Brookes, S. j., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R. L., Fisman, S., Greenhill, L. L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., Tyano, S. (2004). op. cit. 34. Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., Steinhausen, H-C., Zuddas, A. (2004). op. cit. 35.  American Academy of Pediatrics. Subcommittee on AD/HD and Committee of Quality Improvement. (2001). Clinical Practice Guideline: Treatment of the school-aged Children with Attention Deficit / Hyperactivity Disorder. Pediatrics. 108, 1033-1044. 36.  National Institute for Health and Clinical Excellence (2008). Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline 72. National Collaboratin Centre for Mental Health. London.  37. Bernet, W., Dulcan, M. K., Greenhill, L. L., Pliszka, S. R. (2004). Guidelines. Managing: Attention Deficit / Hyperactivity Disorder. Version 2.0. Am Ac Child Adolesc Psychiatry.  38. Kutcher, S., Aman, M., Brookes, S. j., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R. L., Fisman, S., Greenhill, L. L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., Tyano, S. (2004). op. cit. 39. Kutcher, S., Aman, M., Brookes, S. j., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R. L., Fisman, S., Greenhill, L. L., Huss, M., Kusumakar, V., Pine, D., Taylor, E., Tyano, S. (2004). op. cit. 40. Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., Steinhausen, H-C., Zuddas, A. (2004). op. cit. 41. National Institute for Health and Clinical Excellence (2008). op. cit. 42.  National Institute for Health and Clinical Excellence (2008). op. cit. 43.  Henderson, T. A., Hartman, K. (2004). Aggression, mania and hypomania induction associated with atomoxetine. Pediatrics. 114, 3, s. 895-896. 44. Goodman, D. W. (2010). Czarna księga ADHD. Psychiatria po Dyplomie. 7, 3, 12-32. 45. Goodman, D. W. (2010). op. cit. 46. Haxell, P. (2007). Pharmacological management of attention-deficit hyperactyvity disorder. CNS Drugs. 21, 1, 31-46.  47.  American Academy of Pediatrics. Subcommittee on AD/HD and Committee of Quality Improvement. (2001). op. cit. 48. National Institute for Health and Clinical Excellence (2008). op. cit. 49. Wender, E. H. (1986). The foof additive-free diet in the treatment of behavior disorders: a review. J. Dev. Behav. Pediatr. 7, 1, 35-42. 50. Chan, E., Rappaport, L. A., Kemper, K. J. (2003). Complementary and alternative therapies in childhood attention and hyperactivity problems. J. Dev. Behav. Pediatr. 24, 1, 4-8.